| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/13/2023 | 12.55% | Wells Fargo | $16 → $13 | Maintains | Equal-Weight |
| 11/07/2023 | -4.76% | Morgan Stanley | $12 → $11 | Maintains | Underweight |
| 10/16/2023 | 3.9% | Morgan Stanley | $11 → $12 | Maintains | Underweight |
| 10/03/2023 | 21.21% | Wedbush | → $14 | Initiates Coverage On | → Neutral |
| 09/28/2023 | — | Wolfe Research | Initiates Coverage On | → Peer Perform | |
| 09/22/2023 | 38.53% | Truist Securities | → $16 | Reiterates | Hold → Hold |
| 08/25/2023 | -4.76% | Morgan Stanley | $12 → $11 | Maintains | Underweight |
| 07/14/2023 | 29.87% | Citigroup | $16.5 → $15 | Maintains | Neutral |
| 07/12/2023 | 29.87% | Wells Fargo | $14.5 → $15 | Maintains | Equal-Weight |
| 07/10/2023 | 38.53% | Truist Securities | → $16 | Reiterates | Hold → Hold |
| 07/05/2023 | 982.25% | Barclays | $135 → $125 | Maintains | Equal-Weight |
| 06/27/2023 | 3.9% | Morgan Stanley | $13 → $12 | Maintains | Underweight |
| 05/04/2023 | 25.54% | Wells Fargo | $14 → $14.5 | Maintains | Equal-Weight |
| 05/01/2023 | 12.55% | Morgan Stanley | $12 → $13 | Maintains | Underweight |
| 04/27/2023 | 34.2% | Stifel | $15.25 → $15.5 | Maintains | Hold |
| 04/26/2023 | 38.53% | Barclays | $18 → $16 | Maintains | Equal-Weight |
| 04/13/2023 | 38.53% | Truist Securities | $18 → $16 | Maintains | Hold |
| 03/30/2023 | 21.21% | Wells Fargo | $17 → $14 | Maintains | Equal-Weight |
| 02/07/2023 | 3.9% | Morgan Stanley | $13 → $12 | Maintains | Underweight |
| 02/02/2023 | 47.19% | Wells Fargo | $18 → $17 | Maintains | Equal-Weight |
| 02/01/2023 | 42.86% | Citigroup | $15 → $16.5 | Maintains | Neutral |
| 01/18/2023 | 12.55% | Morgan Stanley | $15 → $13 | Maintains | Underweight |
| 12/21/2022 | 55.84% | Barclays | $22 → $18 | Maintains | Equal-Weight |
| 12/09/2022 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 12/05/2022 | 29.87% | Morgan Stanley | → $15 | Initiates Coverage On | → Underweight |
| 12/02/2022 | 55.84% | BMO Capital | $20 → $18 | Downgrades | Outperform → Market Perform |
| 11/01/2022 | 90.48% | Raymond James | $24 → $22 | Maintains | Outperform |
| 10/20/2022 | 55.84% | Truist Securities | $24 → $18 | Maintains | Hold |
| 08/29/2022 | 73.16% | Wells Fargo | → $20 | Downgrades | Overweight → Equal-Weight |
| 07/07/2022 | 90.48% | Barclays | $26 → $22 | Maintains | Equal-Weight |
| 03/23/2022 | — | SMBC Nikko | Initiates Coverage On | → Outperform | |
| 01/10/2022 | — | B of A Securities | Downgrades | Buy → Neutral | |
| 01/10/2022 | 133.77% | Raymond James | → $27 | Upgrades | Market Perform → Outperform |
| 01/07/2022 | 125.11% | BMO Capital | $25 → $26 | Upgrades | Market Perform → Outperform |
| 10/06/2021 | 116.45% | Citigroup | $26 → $25 | Maintains | Neutral |
| 06/14/2021 | — | Evercore ISI Group | Upgrades | Underperform → In-Line | |
| 03/01/2021 | 125.11% | Compass Point | $23.5 → $26 | Upgrades | Neutral → Buy |
| 11/16/2020 | 51.52% | Wells Fargo | $13 → $17.5 | Maintains | Equal-Weight |
| 10/05/2020 | 25.54% | Compass Point | → $14.5 | Initiates Coverage On | → Neutral |
| 09/30/2020 | 29.87% | B of A Securities | $12.5 → $15 | Maintains | Buy |
| 09/29/2020 | 29.87% | B of A Securities | → $15 | Upgrades | Neutral → Buy |
| 07/22/2020 | -0.43% | Wells Fargo | $19 → $11.5 | Maintains | Equal-Weight |
| 06/22/2020 | 29.87% | Barclays | $9 → $15 | Upgrades | Underweight → Equal-Weight |
| 06/12/2020 | 55.84% | RBC Capital | $34 → $18 | Maintains | Outperform |
| 06/08/2020 | 55.84% | Evercore ISI Group | → $18 | Downgrades | In-Line → Underperform |
| 06/05/2020 | 34.2% | Stifel | $13 → $15.5 | Maintains | Hold |
| 05/18/2020 | -22.08% | SunTrust Robinson Humphrey | $10 → $9 | Maintains | Hold |
| 04/29/2020 | -13.42% | SunTrust Robinson Humphrey | $23 → $10 | Maintains | Hold |
| 04/29/2020 | -4.76% | Stifel | $9.5 → $11 | Maintains | Hold |
| 04/07/2020 | -26.41% | Citigroup | $25 → $8.5 | Downgrades | Neutral → Sell |
| 03/17/2020 | -17.75% | Stifel | $20 → $9.5 | Downgrades | Buy → Hold |
| 02/25/2020 | 107.79% | Barclays | $26 → $24 | Maintains | Underweight |
| 01/13/2020 | 159.74% | Capital One | → $30 | Downgrades | Overweight → Equal-Weight |
| 01/13/2020 | — | Capital One | Downgrades | Overweight → Equal-Weight | |
| 01/07/2020 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 11/11/2019 | 125.11% | Barclays | $32 → $26 | Downgrades | Overweight → Underweight |
| 10/21/2019 | 168.4% | Raymond James | $33 → $31 | Maintains | Outperform |
| 10/18/2019 | 133.77% | Wells Fargo | $28 → $27 | Maintains | Market Perform |
| 10/17/2019 | 142.42% | BMO Capital | → $28 | Initiates Coverage On | → Market Perform |
| 08/15/2019 | — | BTIG | Downgrades | Buy → Neutral | |
| 07/17/2019 | 151.08% | B of A Securities | $33 → $29 | Downgrades | Buy → Neutral |
| 06/25/2019 | 203.03% | Capital One | → $35 | Initiates Coverage On | → Overweight |
| 05/06/2019 | — | SunTrust Robinson Humphrey | Initiates Coverage On | → Hold | |
| 03/28/2019 | 177.06% | Citigroup | → $32 | Initiates Coverage On | → Neutral |
| 12/21/2018 | 229% | Raymond James | $40 → $38 | Maintains | Outperform |
What is the target price for Pebblebrook Hotel (PEB)?
The latest price target for Pebblebrook Hotel (NYSE: PEB) was reported by Wells Fargo on November 13, 2023. The analyst firm set a price target for $13.00 expecting PEB to rise to within 12 months (a possible 12.55% upside). 26 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Pebblebrook Hotel (PEB)?
The latest analyst rating for Pebblebrook Hotel (NYSE: PEB) was provided by Wells Fargo, and Pebblebrook Hotel maintained their equal-weight rating.
When is the next analyst rating going to be posted or updated for Pebblebrook Hotel (PEB)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Pebblebrook Hotel, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Pebblebrook Hotel was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.
Is the Analyst Rating Pebblebrook Hotel (PEB) correct?
While ratings are subjective and will change, the latest Pebblebrook Hotel (PEB) rating was a maintained with a price target of $16.00 to $13.00. The current price Pebblebrook Hotel (PEB) is trading at is $11.55, which is out of the analyst's predicted range.